✦ LIBER ✦

Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer

✍ Scribed by Heinemann, V; Ebert, M P; Laubender, R P; Bevan, P; Mala, C; Boeck, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of gemcitabine plus axitinib co

✍ Jean-Philippe Spano; Catherine Chodkiewicz; Joan Maurel; Ralph Wong; Harpreet Wa 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 191 KB

A randomized multi-center phase II trial

✍ Helmut Friess; Jan M Langrehr; Helmut Oettle; Jochen Raedle; Marco Niedergethman 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 388 KB

Results of the phase I-II study of gemci

✍ Faivre, S; Monnerat, C; Raymond, E; Taieb, J; Adi Vago, N; Vicente-Azevedo, J; R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A randomized phase II study of PX-12, an

✍ Ramesh K. Ramanathan; James Abbruzzese; Tomislav Dragovich; Lynn Kirkpatrick; Jo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 267 KB

The combination of gemcitabine and oxali

✍ V. Franciosi; R. Barbieri; G. Vasini; E. Aitini; C. Cacciani; R. Capra; F. Greco 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

9003 ORAL Biomarker Analysis in BO21015,

✍ Mok, T.; Gorbunova, V.; Juhasz, E.; Szima, B.; Burdaeva, O.; Yu, C.J.; Delmar, P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB